Abbott Laboratories (Pakistan) (KAR:ABOT) Other Operating Expense : ₨4,431 Mil (TTM As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Abbott Laboratories (Pakistan) Other Operating Expense?

Abbott Laboratories (Pakistan)'s Other Operating Expense for the three months ended in Mar. 2024 was ₨138 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₨4,431 Mil.

Abbott Laboratories (Pakistan)'s quarterly Other Operating Expense increased from Sep. 2023 (₨16 Mil) to Dec. 2023 (₨4,182 Mil) but then declined from Dec. 2023 (₨4,182 Mil) to Mar. 2024 (₨138 Mil).

Abbott Laboratories (Pakistan)'s annual Other Operating Expense increased from Dec. 2021 (₨3,702 Mil) to Dec. 2022 (₨3,910 Mil) and increased from Dec. 2022 (₨3,910 Mil) to Dec. 2023 (₨4,253 Mil).

Abbott Laboratories (Pakistan) Other Operating Expense Historical Data

The historical data trend for Abbott Laboratories (Pakistan)'s Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories (Pakistan) Other Operating Expense Chart

Abbott Laboratories (Pakistan) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

3,053.62

3,255.91

3,702.05

3,910.24

4,253.36

Abbott Laboratories (Pakistan) Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															15.29	95.29	16.43	4,181.77	137.62

Abbott Laboratories (Pakistan) Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨4,431 Mil.

Abbott Laboratories (Pakistan) Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories (Pakistan)'s Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (Pakistan) (KAR:ABOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott Laboratories (Pakistan) Ltd (KAR:ABOT) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Hyderabad Road, Landhi, P.O. Box 7229, Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Karachi, PAK, 75120

Website

https://www.pk.abbott

Abbott Laboratories (Pakistan) Ltd is engaged in manufacturing, importing, and marketing research-based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products. Its operating segments are Pharmaceutical, Nutritional, Diagnostics, and Others. It generates maximum revenue from the Pharmaceutical segment. Geographically, it derives the majority of its revenue from Pakistan and also has a presence in Afghanistan, Sri Lanka, Bangladesh, and Switzerland. Its Brands include Duphaston, Surbex Z, Serc, Duphala, Pediasur, Similac, and others.

Abbott Laboratories (Pakistan) (KAR:ABOT) Headlines

No Headlines